Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Giorgini

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|August 30, 2005
Primary biliary cirrhosis: solving the enigmaAlessia Giorgini, Carlo Selmi, Pietro Invernizzi, et al.
Internal and Emergency Medicine|November 18, 2019
Liver alterations in anorexia nervosa are not caused by insulin resistanceAlice Fanin, Lucia Miele, Emanuela Bertolini, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 6, 2007
Helicobacter pylori infection in hepatic encephalopathy: Relationship to plasma endotoxins and blood ammoniaHassan Abdel-Hady, Ali Zaki, Gamal Badra, et al.
Medicine|July 7, 2018
Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational studyGiovanni Battista Gaeta, Alessio Aghemo, Barbara Menzaghi, et al.
Annals of the New York Academy of Sciences|September 18, 2009
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxisAlessia Giorgini, Franco Capsoni, Mauro Podda, et al.
Expert Opinion on Drug Safety|April 21, 2021
Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life studyNicola Pugliese, Alessia Giorgini, Daniela Maggi, et al.
Clinical Case Reports|December 28, 2020
SARS-CoV-2-related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point-of-care ultrasoundAndrea Galassi, Francesca Casanova, Lidia Gazzola, et al.
BMC Infectious Diseases|May 5, 2021
Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Xhimi Tata, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 24, 2021
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Xhimi Tata, et al.
Journal of Viral Hepatitis|December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life settingMassimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|August 30, 2005
Primary biliary cirrhosis: solving the enigmaAlessia Giorgini, Carlo Selmi, Pietro Invernizzi, et al.
Internal and Emergency Medicine|November 18, 2019
Liver alterations in anorexia nervosa are not caused by insulin resistanceAlice Fanin, Lucia Miele, Emanuela Bertolini, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 6, 2007
Helicobacter pylori infection in hepatic encephalopathy: Relationship to plasma endotoxins and blood ammoniaHassan Abdel-Hady, Ali Zaki, Gamal Badra, et al.
Medicine|July 7, 2018
Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational studyGiovanni Battista Gaeta, Alessio Aghemo, Barbara Menzaghi, et al.
Annals of the New York Academy of Sciences|September 18, 2009
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxisAlessia Giorgini, Franco Capsoni, Mauro Podda, et al.
Expert Opinion on Drug Safety|April 21, 2021
Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life studyNicola Pugliese, Alessia Giorgini, Daniela Maggi, et al.
Clinical Case Reports|December 28, 2020
SARS-CoV-2-related ARDS in a maintenance hemodialysis patient: case report on tailored approach by daily hemodialysis, noninvasive ventilation, tocilizumab, anxiolytics, and point-of-care ultrasoundAndrea Galassi, Francesca Casanova, Lidia Gazzola, et al.
BMC Infectious Diseases|May 5, 2021
Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Xhimi Tata, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 24, 2021
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Xhimi Tata, et al.
Journal of Viral Hepatitis|December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life settingMassimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.
Pageof 2